Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$342K Buy
2,665
+55
+2% +$6.44K 0.15% 80
2026
Q1
$314K Sell
2,610
-587
-18% -$67.8K 0.14% 86
2025
Q4
$337K Buy
3,197
+491
+18% +$46.1K 0.13% 85
2025
Q3
$227K Buy
+2,706
New +$223K 0.09% 109

Other funds holding MRK

Cura Wealth Advisors's MRK Position: Q2 2026 in Review

Cura Wealth Advisors increased its Merck (MRK) stake by 2.1% in Q2 2026, buying an estimated $6.44K and bringing the position to 2,665 shares worth $342K. The position accounts for 0.15% of the portfolio, ranked #80.

Cura Wealth Advisors first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cura Wealth Advisors held 2,665 shares of Merck worth $342K as of Q2 2026.
  • Cura Wealth Advisors bought 55 Merck shares in Q2 2026, an estimated $6.44K.
  • Merck made up 0.15% of Cura Wealth Advisors's portfolio in Q2 2026, its #80 holding.
  • Cura Wealth Advisors first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cura Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.